Medical Devices & Tech

Symphony Medical

26051 Merit Circle Ste 102
Laguna Hills, CA 92653 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Biocompatible Polymers and Cell Therapies to Treat Heart Disease

Management Raymond W. Cohen, Chief Executive Officer and member of the Board of Directors; Frank A. Ahmann, Chief Operating Officer; Sam L. Helgerson, Ph.D., Chief Scientific Officer; Andy G. Hinson, Vice President, Clinical and Regulatory Affairs; Roderick de Greef, Chief Financial Officer (Consultant)

Click here for Financial Data
Keywords: regurgitation, abnormalities, biotherapeutic, prophylactic, biocompatible


Updated: Aug. 22, 2013


Symphony Medical, Inc., is a privately-held development-stage company with proprietary biopolymer and biotherapeutic devices directed toward heart failure, post-operative atrial fibrillation (POAF) an......view more

Products / Services

The company has two products in its late-stage development pipeline. Algisyl-LVR is a treatment to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation (MR). Plex......view more

Technology / Differentiation

Symphony's products employ proprietary biocompatible polymers delivered into specific locations of the heart during either open chest surgery or via a minimally invasive procedure. The biopolymers are...view more

Market / Customers

Chronic heart failure and mitral valve regurgitation related to dilated cardiomyopathy are lethal conditions in which a patient's heart loses functionality and blood-pumping capability. These conditio......view more


A capital-efficient approach toward product development has allowed Symphony to achieve significant milestones by conducting the majority of research in the university setting and at commercial labora...view more


Algisyl-LVR has completed large animal preclinical testing and is planning a multi-center European clinical study for the first quarter of 2009. An IDE for Algisyl-LVR was filed with the FDA in Decemb...view more